Increased thromboxane biosynthesis during coronary thrombolysis. Evidence that platelet activation and thromboxane A2 modulate the response to tissue-type plasminogen activator in vivo

Circulation Research
D J FitzgeraldG A FitzGerald

Abstract

Platelet activation is markedly increased during coronary thrombolysis and limits the response to thrombolytic therapy. A possible mediator of platelet activation in this setting is thromboxane (TX) A2, a potent platelet agonist formed in greatly increased amounts during coronary thrombolysis in man. To address this hypothesis, we examined the role of TXA2 in modulating the response to intravenous tissue-type plasminogen activator (t-PA) in a chronic canine model of coronary thrombosis. Reperfusion occurred in 60 +/- 5 minutes and was complicated by spontaneous reocclusion. The times to reperfusion and reocclusion were platelet-dependent. Consistent with a role for TXA2 in this process, TXA2 biosynthesis, determined a excretion of its enzymatic metabolite, 2,3-dinor-TXB2, was markedly increased during coronary thrombolysis. Furthermore, inhibition of TXA2 by aspirin, given alone or in combination with a TXA2/prostaglandin endoperoxide receptor antagonist, accelerated reperfusion and partly inhibited cyclic flow variations during reperfusion. The delay in reperfusion and reocclusion induced by TXA2 appeared to be mediated by platelet aggregation since the F(ab')2 fragment of 7E3, a monoclonal antibody to the platelet GPIIb/IIIa,...Continue Reading

References

Sep 1, 1977·Analytical Biochemistry·F A FitzpatrickF F Sun
Mar 22, 1976·European Journal of Clinical Pharmacology·K E WirthJ A Oates
Jul 1, 1985·Journal of Cardiovascular Pharmacology·W A SchumacherB R Lucchesi
Feb 1, 1986·The Journal of Clinical Investigation·D J FitzgeraldG A FitzGerald
Nov 1, 1988·The Journal of Clinical Investigation·D J FitzgeraldG A FitzGerald
Jan 28, 1988·The New England Journal of Medicine·UNKNOWN Steering Committee of the Physicians' Health Study Research Group
Oct 16, 1986·The New England Journal of Medicine·D J FitzgeraldG A FitzGerald
Sep 15, 1987·Thrombosis Research·F Catella, G A FitzGerald
Apr 4, 1985·The New England Journal of Medicine·UNKNOWN TIMI Study Group
Oct 1, 1984·The Journal of Clinical Investigation·L A EricksonD J Loskutoff
Nov 1, 1981·The Journal of Clinical Investigation·G A FitzGeraldJ A Oates
Aug 1, 1963·The Journal of Physiology·G V BORN, M J CROSS

❮ Previous
Next ❯

Citations

Jan 1, 1994·Journal of Clinical Pharmacology·L A Harker
Feb 1, 1992·Cardiovascular Drugs and Therapy·J Vermylen, H Deckmyn
Jun 6, 1991·European Journal of Pharmacology·H P Rounding, V B Fiedler
Nov 24, 1995·International Journal of Cardiology·L R van der WiekenW Vrolik
Mar 1, 1990·Journal of the American College of Cardiology·J L Mehta
Nov 15, 1991·Journal of the American College of Cardiology·S FujiiB E Sobel
Nov 1, 1995·Journal of the American College of Cardiology·T TomaruY Uchida
Jan 1, 1991·Trends in Cardiovascular Medicine·D J Fitzgerald, G A Fitzgerald
Mar 1, 1991·Journal of the American College of Cardiology·J L MehtaT G Saldeen
Sep 2, 1993·The New England Journal of Medicine·H V Anderson, J T Willerson
Mar 20, 1997·The New England Journal of Medicine·R CollinsP Sleight
Oct 1, 1989·Proceedings of the National Academy of Sciences of the United States of America·D J Fitzgerald, G A Fitzgerald
Jan 1, 1992·British Journal of Clinical Pharmacology·M CahillD B Barnett
Jan 5, 2013·Circulation Research·Desmond J Fitzgerald, Garret A Fitzgerald
Nov 1, 1991·The Journal of Clinical Investigation·D J FitzgeraldG A FitzGerald
Jan 20, 2009·Journal of Lipid Research·Stephen J WilsonEmer M Smyth
Jan 1, 1989·Journal of Internal Medicine. Supplement·G A FitzgeraldH R Knapp
Sep 12, 2000·Current Cardiology Reports·I Conde-Pozzi, N Kleiman
Jan 1, 1991·Platelets·B Pasche, J Loscalzo
Jan 3, 1992·The American Journal of Cardiology·R C Becker
Feb 1, 1993·American Heart Journal·T G SaldeenJ L Mehta
Sep 1, 1994·Baillière's Clinical Haematology·L A Harker, S R Hanson
Dec 16, 1993·The American Journal of Cardiology·G Agnelli
Dec 16, 1993·The American Journal of Cardiology·P A MerliniP M Mannucci
Aug 1, 1991·The American Journal of Cardiology·B E Sobel, J Hirsh
Aug 15, 1991·Archives of Biochemistry and Biophysics·L IulianoF Violi

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood Coagulation Signaling Pathways

Coagulation is the process by which a blood clot is formed. This process includes both the formation of a platelet plug as well as a cascade of clotting factors resulting in the formation of fibrin strands. Find the latest research on coagulation signaling pathways here.

Blood Clotting Disorders

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.